$0.04
0[0.00%]
Last update: 1:19PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 66.500K | Mkt Cap45.680M |
| Day Range- - - | 52 Wk Range0.025 - 0.200 |
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemogenyx Pharmaceuticals Stock (OTC:HOPHF), Key Statistics
Hemogenyx Pharmaceuticals Stock (OTC: HOPHF) analysis, key statistics.
Valuation Measures
Enterprise Value
28.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
10.26
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-23.34%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.8M
Total Assets
7.1M
Total Liabilities
3.8M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -